DiaMedica Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -6,883 | -10 | -8 | |
EBITDA | -8,408 | -6,873 | -5,628 | -5,733 |
EBIT | -8,419 | -6,883 | -5,638 | -5,741 |
Net Income | -7,900 | -6,274 | -5,119 | -5,151 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,441 | -4,479 | -4,519 | -6,662 |
Cash | 3,025 | 4,134 | 14,066 | 2,097 |
Basic Shares | 41,578 | 42,751 | 38,068 | 37,958 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -30 | -25 | -24 | |
EBITDA | -19,308 | -13,976 | -13,622 | |
EBIT | -19,338 | -14,001 | -13,646 | |
Net Income | -24,444 | -19,381 | -13,676 | -13,592 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -22,101 | -18,752 | -11,592 | -12,274 |
Cash | 3,025 | 4,543 | 4,728 | 4,707 |
Basic Shares | 40,404 | 32,566 | 26,443 | 20,773 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.18 |
2024-09-30 | -$0.15 |
2024-06-30 | -$0.13 |
2024-03-31 | -$0.14 |
